New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch ...
Yale School of Medicine will jointly lead a new national research consortium focused on epidermal differentiation disorders, ...
Company on track to initiate first-ever formal clinical trial in Peeling Skin Syndrome before year end – Orphan Drug ...
A large matched cohort study using U.S. electronic health records finds that patients with pityriasis rubra pilaris have ...
Acquisition adds high-payload herpes simplex virus (HSV) gene therapy targeting genetic skin diseases to LEO Pharma's pipeline and further expands the company's presence in rare dermatology Combines ...
Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the ...
A 56-year-old woman being treated with pembrolizumab for advanced skin cancer developed one of the rarest immune-related skin reactions ever documented, and her case is now drawing attention because ...
People with Sweet's syndrome often wake up with a fever, body aches, and blisters on their neck, limbs and face. Also known as acute febrile neutrophilic dermatosis, it is an inflammatory skin disease ...
Proceeds to support continued clinical development of ontivatrep, an oral TRPV3 inhibitor, with Phase 1b topline results in Olmsted syndrome ...
The human body is capable of extraordinary things — but it’s also capable of going spectacularly, bewilderingly wrong in ways most people never imagined. From a man whose gut brews its own alcohol to ...
Skin is often described as a mirror of your overall health. While many skin issues are harmless and temporary, some visible changes may signal deeper health problems within the body. Doctors often say ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Poster #76954 highlights QTORIN™ rapamycin’s single ...